Suppr超能文献

糖尿病的命运掌握在我们手中:实现代谢因果报应。

Diabetes Destiny in our Hands: Achieving Metabolic Karma.

作者信息

Kalra Sanjay, Ved Jignesh, Baruah Manash P

机构信息

Department of Endocrinology, Bharti Hospital, Karnal, Haryana, India.

Department of Medical Affairs, Boehringer Ingelheim, Mumbai, Maharashtra, India.

出版信息

Indian J Endocrinol Metab. 2017 May-Jun;21(3):482-483. doi: 10.4103/ijem.IJEM_571_16.

Abstract

Karma is the ancient Indian philosophy of cause and effect, which implies that an individual's intentions, and actions, both have consequences. None can escape the consequences of one's actions. Applying the principle of karma to medicine and healthcare, the significance of optimal and timely interventions at various stages of disease, may be realized. A holistic approach to metabolic control in diabetes translates into improved clinical outcomes, as evident from the result of STENO-2, EMPA-REG OUTCOME, or LEADER trials. The principle of karma in the management of diabetes may have implications at the transgenerational level during pregnancy and nursing, at the individual patient-level based on phenotype, and at the community level in preventive medicine. The concept of metabolic karma can be used as an effective motivational tool to encourage better health care seeking behavior and adherence to prescribed interventions.

摘要

因果报应是古印度的因果哲学,意味着个人的意图和行为都会产生后果。没有人能逃脱自己行为的后果。将因果报应原则应用于医学和医疗保健,可以认识到在疾病各个阶段进行最佳和及时干预的重要性。糖尿病代谢控制的整体方法转化为更好的临床结果,这在STENO-2、EMPA-REG OUTCOME或LEADER试验的结果中很明显。糖尿病管理中的因果报应原则可能在怀孕和哺乳期间的跨代层面、基于表型的个体患者层面以及预防医学的社区层面产生影响。代谢因果报应的概念可以用作一种有效的激励工具,以鼓励更好的医疗保健寻求行为和坚持规定的干预措施。

相似文献

1
Diabetes Destiny in our Hands: Achieving Metabolic Karma.
Indian J Endocrinol Metab. 2017 May-Jun;21(3):482-483. doi: 10.4103/ijem.IJEM_571_16.
2
Glycemic exposure, glycemic control, and metabolic karma in diabetic complications.
Adv Chronic Kidney Dis. 2014 May;21(3):311-7. doi: 10.1053/j.ackd.2014.03.004.
3
Babies born dying: just bad karma? A discussion paper.
J Relig Health. 2014 Dec;53(6):1753-8. doi: 10.1007/s10943-013-9779-x.
4
Mortality Reduction in EMPA-REG OUTCOME Trial: Beyond the Antidiabetes Effect.
Diabetes Care. 2018 Feb;41(2):219-223. doi: 10.2337/dc17-1059.
5
Metabolic memory: Evolving concepts.
J Diabetes. 2018 Mar;10(3):186-187. doi: 10.1111/1753-0407.12622. Epub 2017 Dec 11.
8
9
Diabetes Management and the Buddhist Philosophy: Toward Holistic Care.
Indian J Endocrinol Metab. 2018 Nov-Dec;22(6):806-811. doi: 10.4103/ijem.IJEM_285_17.
10
NIH consensus development conference: diagnosing gestational diabetes mellitus.
NIH Consens State Sci Statements. 2013 Mar 6;29(1):1-31.

引用本文的文献

1
Forty-four Years of the UK Prospective Diabetes Study: Legacy Effect and Beyond.
touchREV Endocrinol. 2025 May;21(1):2-3. doi: 10.17925/EE.2025.21.1.8. Epub 2024 Nov 20.
2
BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion.
Diabetes Ther. 2019 Aug;10(4):1189-1204. doi: 10.1007/s13300-019-0629-z. Epub 2019 May 17.
3
Diabetes Management and the Buddhist Philosophy: Toward Holistic Care.
Indian J Endocrinol Metab. 2018 Nov-Dec;22(6):806-811. doi: 10.4103/ijem.IJEM_285_17.
4
Sulfonylureas at the Glomerular Battlefield.
Eur Endocrinol. 2018 Sep;14(2):15-17. doi: 10.17925/EE.2018.14.2.15. Epub 2018 Sep 10.
5
Karma and Diabetes Mellitus.
Indian J Endocrinol Metab. 2017 Nov-Dec;21(6):930-931. doi: 10.4103/ijem.IJEM_313_17.

本文引用的文献

2
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13.
3
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17.
4
Quaternary prevention and diabetes.
J Pak Med Assoc. 2014 Nov;64(11):1324-6.
5
Glycemic exposure, glycemic control, and metabolic karma in diabetic complications.
Adv Chronic Kidney Dis. 2014 May;21(3):311-7. doi: 10.1053/j.ackd.2014.03.004.
6
Vascular memory: can we broaden the concept of the metabolic memory?
Cardiovasc Diabetol. 2012 Apr 30;11:44. doi: 10.1186/1475-2840-11-44.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验